𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study

✍ Scribed by Jong Gwang Kim; Sang Kyun Sohn; Yee Soo Chae; Yoon Young Cho; Deok Hwan Yang; Je-Jung Lee; Hyeoung-Joon Kim; Ho Jin Shin; Joo Seop Chung; Goon Jae Cho; Won-Sik Lee; Young-Don Joo; Chang-Hak Sohn; Suk Joong Oh

Book ID
105992624
Publisher
Springer
Year
2007
Tongue
English
Weight
267 KB
Volume
60
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of paclitaxel plus carb
A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma
✍ Edith A. Perez; David W. Hillman; Philip J. Stella; James E. Krook; Lynn C. Hart πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 3 views

## BACKGROUND. This Phase II multicenter study evaluated the efficacy and toxicity of paclitaxel (200 mg/m 2 by 3-hour infusion) with carboplatin (area under the curve 6 mg/mL per minute) administered every 3 weeks as first-line therapy for women with metastatic breast carcinoma. ## METHODS. Eligi